Shree Ganesh Remedies last traded at ₹678.65 (2026-10-13). Over the past month the stock moved +7.0%, three months the stock moved +4.5%, year the stock moved +23.7%. Its closing range over 52 weeks is ₹423.05 – ₹725.50, with the latest close 6.5% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1995, Shree Ganesh Remedies Ltd is a manufacturer of Pharmaceutical Drug Intermediates for API & Fine Chemicals[1]
Business Overview:[1] SGRL is an ISO 14001 certified complex chemical manufacturer, specialising in pharmaceutical intermediates and speciality chemicals.
In the latest quarter (Jun 2026), Shree Ganesh Remedies reported sales of ₹14.36 crore (-41.8%) and net profit of ₹1.12 crore (-67.5%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 14.36 | 3.35 | 23.33 | 1.12 | 0.87 |
| Mar 2026 | 33.20 | 11.38 | 34.28 | 6.27 | 4.88 |
| Dec 2025 | 21.11 | 6.73 | 31.88 | 3.10 | 2.41 |
| Sep 2025 | 30.32 | 9.62 | 31.73 | 4.96 | 3.86 |
| Jun 2025 | 24.67 | 7.30 | 29.59 | 3.45 | 2.69 |
| Mar 2025 | 24.43 | 9.88 | 40.44 | 6.60 | 5.14 |
| Dec 2024 | 27.05 | 9.91 | 36.64 | 5.43 | 4.23 |
| Sep 2024 | 32.33 | 11.31 | 34.98 | 6.42 | 5.00 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -3.3% | -3.3% | -34.6% | -0.4% | -6.2% | -22.0% | +35.9% | -41.8% |
| Operating profit growth | +22.5% | +20.7% | -41.7% | -10.2% | -14.9% | -32.1% | +15.2% | -54.1% |
| Net profit growth | -2.0% | +13.1% | -47.6% | -25.8% | -22.7% | -42.9% | -5.0% | -67.5% |
| EPS growth | -2.3% | +12.8% | -47.8% | -25.7% | -22.8% | -43.0% | -5.1% | -67.7% |
| OPM % | 35.0% | 36.6% | 40.4% | 29.6% | 31.7% | 31.9% | 34.3% | 23.3% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Shree Ganesh Remedies reported sales of ₹109.00 crore (+0.0%) and net profit of ₹18.00 crore (-21.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 109.00 | 35.00 | 32.00 | 18.00 | 13.84 |
| Mar 2025 | 109.00 | 39.00 | 36.00 | 23.00 | 18.00 |
| Mar 2024 | 126.00 | 42.00 | 33.00 | 28.00 | 21.97 |
| Mar 2023 | 91.00 | 23.00 | 26.00 | 15.00 | 11.86 |
| Mar 2022 | 71.00 | 18.00 | 25.00 | 13.00 | 10.47 |
| Mar 2021 | 49.00 | 14.00 | 28.00 | 10.00 | 7.62 |
| Mar 2020 | 58.00 | 11.00 | 19.00 | 10.00 | 7.52 |
| Mar 2019 | 35.00 | 9.00 | 25.00 | 6.00 | 4.88 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +29.6% | +65.7% | -15.5% | +44.9% | +28.2% | +38.5% | -13.5% | +0.0% |
| Operating profit growth | +80.0% | +22.2% | +27.3% | +28.6% | +27.8% | +82.6% | -7.1% | -10.3% |
| Net profit growth | +20.0% | +66.7% | +0.0% | +30.0% | +15.4% | +86.7% | -17.9% | -21.7% |
| EPS growth | +33.3% | +54.1% | +1.3% | +37.4% | +13.3% | +85.2% | -18.1% | -23.1% |
| OPM % | 25.0% | 19.0% | 28.0% | 25.0% | 26.0% | 33.0% | 36.0% | 32.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Shree Ganesh Remedies.
Get Free AI Stock Analysis FREE →Shree Ganesh Remedies AGM passes all resolutions with 99.99% shareholder support - scanx.trade
Shree Ganesh Remedies consolidated net profit declines 67.54% in the June 2026 quarter - Business Standard
Shree Ganesh Remedies Schedules Q4 & FY26 Earnings Conference Call for May 15, 2026 - scanx.trade
Shree Ganesh Remedies shares were last quoted at ₹678.65 (-0.4% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Shree Ganesh Remedies has a price-to-earnings (P/E) ratio of 56.16 and a price-to-book (P/B) ratio of 5.29. The industry P/E is 53.33.
The 52-week high of Shree Ganesh Remedies is ₹759.00 and the 52-week low is ₹381.10.
The market capitalisation of Shree Ganesh Remedies is about ₹866.54 crore.
In the latest quarter (Jun 2026), Shree Ganesh Remedies reported sales of ₹14.36 crore (-41.8%) and net profit of ₹1.12 crore (-67.5%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Shree Ganesh Remedies has a 3-year ROE of 17.00%, 3-year profit growth of 5.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 72.84% of Shree Ganesh Remedies.
Shree Ganesh Remedies belongs to the Pharmaceuticals & Drugs sector.